Clinical trials
Hyperlipidemias trials in China
Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.
90 trials match Source: ClinicalTrials.gov registrations
Trials started per year
By phase, 2000 to 2026.
| Category | Trials |
|---|---|
| 2005 | 1 |
| 2008 | 2 |
| 2009 | 3 |
| 2010 | 1 |
| 2011 | 3 |
| 2013 | 1 |
| 2014 | 1 |
| 2015 | 2 |
| 2016 | 1 |
| 2017 | 2 |
| 2018 | 2 |
| 2019 | 2 |
| 2020 | 9 |
| 2021 | 6 |
| 2022 | 9 |
| 2023 | 10 |
| 2024 | 11 |
| 2025 | 11 |
| 2026 | 13 |
Status
Trials by registry status. Select a bar to filter.
| Category | Trials |
|---|---|
| Completed | 41 |
| Unknown status | 18 |
| Recruiting | 15 |
| Not yet recruiting | 9 |
| Active, not recruiting | 5 |
| Terminated | 1 |
| Enrolling by invitation | 1 |
Top lead sponsors
A sponsor with a page on Pharma Observatory links to it.
| Category | Trials |
|---|---|
| Novartis Pharmaceuticals | 7 |
| Shandong Suncadia Medicine Co., Ltd. | 5 |
| Shanghai Junshi Bioscience Co., Ltd. | 5 |
| Akeso | 3 |
| Beijing Suncadia Pharmaceuticals Co., Ltd | 3 |
| China National Center for Cardiovascular Diseases | 3 |
| Fujian Shengdi Pharmaceutical Co., Ltd. | 3 |
| Jiangsu HengRui Medicine Co., Ltd. | 3 |
| Peking University Third Hospital | 3 |
| Shenzhen Salubris Pharmaceuticals Co., Ltd. | 3 |
Top conditions
MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.
| Category | Trials |
|---|---|
| Hyperlipidemias | 90 |
| Hypertension | 10 |
| Cardiovascular Diseases | 7 |
| Dyslipidemias | 7 |
| Hypercholesterolemia | 7 |
| Coronary Artery Disease | 6 |
| Atherosclerosis | 5 |
| Diabetes Mellitus | 5 |
| Obesity | 5 |
| Stroke | 4 |
Trials
Showing 76 to 90 of 90. Each trial links to its page on Pharma Observatory.
Recently changed trials
Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.
No changes to these trials in the last 7 days.
Go deeper on Pharma Observatory
Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.